Literature DB >> 26223837

Regional gastrointestinal transit and pH studied in 215 healthy volunteers using the wireless motility capsule: influence of age, gender, study country and testing protocol.

Y T Wang1, S D Mohammed1, A D Farmer1,2, D Wang3, N Zarate4, A R Hobson5, P M Hellström6, J R Semler7, B Kuo8, S S Rao9, W L Hasler10, M Camilleri11, S M Scott1.   

Abstract

BACKGROUND: The wireless motility capsule (WMC) offers the ability to investigate luminal gastrointestinal (GI) physiology in a minimally invasive manner. AIM: To investigate the effect of testing protocol, gender, age and study country on regional GI transit times and associated pH values using the WMC.
METHODS: Regional GI transit times and pH values were determined in 215 healthy volunteers from USA and Sweden studied using the WMC over a 6.5-year period. The effects of test protocol, gender, age and study country were examined.
RESULTS: For GI transit times, testing protocol was associated with differences in gastric emptying time (GET; shorter with protocol 2 (motility capsule ingested immediately after meal) vs. protocol 1 (motility capsule immediately before): median difference: 52 min, P = 0.0063) and colonic transit time (CTT; longer with protocol 2: median 140 min, P = 0.0189), but had no overall effect on whole gut transit time. Females had longer GET (by median 17 min, P = 0.0307), and also longer CTT by (104 min, P = 0.0285) and whole gut transit time by (263 min, P = 0.0077). Increasing age was associated with shorter small bowel transit time (P = 0.002), and study country also influenced small bowel and CTTs. Whole gut and CTTs showed clustering of data at values separated by 24 h, suggesting that describing these measures as continuous variables is invalid. Testing protocol, gender and study country also significantly influenced pH values.
CONCLUSIONS: Regional GI transit times and pH values, delineated using the wireless motility capsule (WMC), vary based on testing protocol, gender, age and country. Standardisation of testing is crucial for cross-referencing in clinical practice and future research.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26223837     DOI: 10.1111/apt.13329

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  37 in total

1.  Intraluminal pH As a Pathophysiological Biomarker of Fermentation in Irritable Bowel Syndrome.

Authors:  Adam D Farmer; Anthony R Hobson
Journal:  Am J Gastroenterol       Date:  2016-01       Impact factor: 10.864

2.  Long-term flow through human intestinal organoids with the gut organoid flow chip (GOFlowChip).

Authors:  Barkan Sidar; Brittany R Jenkins; Sha Huang; Jason R Spence; Seth T Walk; James N Wilking
Journal:  Lab Chip       Date:  2019-10-09       Impact factor: 6.799

Review 3.  The Wireless Motility Capsule: a One-Stop Shop for the Evaluation of GI Motility Disorders.

Authors:  Richard J Saad
Journal:  Curr Gastroenterol Rep       Date:  2016-03

Review 4.  More movement with evaluating colonic transit in humans.

Authors:  Adil E Bharucha; Bradley Anderson; Michel Bouchoucha
Journal:  Neurogastroenterol Motil       Date:  2019-02       Impact factor: 3.598

Review 5.  Small Bowel Motility.

Authors:  Carolina Malagelada; Juan R Malagelada
Journal:  Curr Gastroenterol Rep       Date:  2017-06

6.  Gastrointestinal pH, Motility Patterns, and Transit Times After Roux-en-Y Gastric Bypass.

Authors:  Louise Ladebo; Pernille V Pedersen; Grzegorz J Pacyk; Jens Peter Kroustrup; Asbjørn M Drewes; Christina Brock; Anne E Olesen
Journal:  Obes Surg       Date:  2021-03-12       Impact factor: 4.129

7.  Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double-blind, placebo-controlled trial.

Authors:  Anne-Marie Langmach Wegeberg; Christian Stevns Hansen; Adam D Farmer; Jesper Scott Karmisholt; Asbjorn M Drewes; Poul Erik Jakobsen; Birgitte Brock; Christina Brock
Journal:  United European Gastroenterol J       Date:  2020-05-09       Impact factor: 4.623

8.  Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis.

Authors:  W L Hasler; K P May; L A Wilson; M Van Natta; H P Parkman; P J Pasricha; K L Koch; T L Abell; R W McCallum; L A Nguyen; W J Snape; I Sarosiek; J O Clarke; G Farrugia; J Calles-Escandon; M Grover; J Tonascia; L A Lee; L Miriel; F A Hamilton
Journal:  Neurogastroenterol Motil       Date:  2017-09-05       Impact factor: 3.598

9.  Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility.

Authors:  Susanna Every-Palmer; Stephen J Inns; Eve Grant; Pete M Ellis
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

10.  Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut.

Authors:  Henrik M Roager; Lea B S Hansen; Martin I Bahl; Henrik L Frandsen; Vera Carvalho; Rikke J Gøbel; Marlene D Dalgaard; Damian R Plichta; Morten H Sparholt; Henrik Vestergaard; Torben Hansen; Thomas Sicheritz-Pontén; H Bjørn Nielsen; Oluf Pedersen; Lotte Lauritzen; Mette Kristensen; Ramneek Gupta; Tine R Licht
Journal:  Nat Microbiol       Date:  2016-06-27       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.